Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol Lett ; 127(1-3): 197-205, 2002 Feb 28.
Article in English | MEDLINE | ID: mdl-12052659

ABSTRACT

Developmental neurotoxicity can be ascribed to in utero exposure to exogenous substances or to exposure of the fetus to endogenous compounds that accumulate because of genetic mutations. One of the best recognized human neuroteratogens is ethanol. The Fetal Alcohol Syndrome (FAS) is characterized by growth deficiency, particular facial features, and central nervous system (CNS) dysfunctions (mental retardation, microencephaly and brain malformations). Abuse of toluene by pregnant women can lead to an embryopathy (fetal solvent syndrome, (FSS)) whose characteristics are similar to FAS. Phenylketonuria (PKU) is a genetic defect in phenylalanine (Phe) metabolism. Offspring of phenylketonuric mothers not under strict dietary control are born with maternal PKU (mPKU), a syndrome with similar characteristics as FAS and FSS. While ethanol has been shown to cause neuronal death, no such evidence is available for toluene or Phe and/or its metabolites. On the other hand, alterations in astrocyte proliferation and maturation have been found, mostly in in vitro studies, which may represent a potential common mode of action for at least some of the CNS effects found in FAS, mPKU, and FSS. Further in vivo and in vitro studies should validate this hypothesis and elucidate possible molecular targets.


Subject(s)
Maternal Exposure/adverse effects , Nervous System Diseases/embryology , Xenobiotics/adverse effects , Alcohol-Induced Disorders, Nervous System/embryology , Alcohol-Induced Disorders, Nervous System/etiology , Animals , Ethanol/adverse effects , Ethanol/toxicity , Female , Fetal Alcohol Spectrum Disorders/etiology , Fetal Alcohol Spectrum Disorders/pathology , Humans , Nervous System Diseases/etiology , Nervous System Diseases/genetics , Neurotoxicity Syndromes , Phenotype , Phenylketonuria, Maternal/complications , Pregnancy , Toluene/adverse effects , Toluene/toxicity , Xenobiotics/toxicity
2.
Growth Factors ; 18(4): 227-36, 2001.
Article in English | MEDLINE | ID: mdl-11519822

ABSTRACT

Acetylcholine muscarinic receptors are a family of five G-protein-coupled receptors widely distributed in the central nervous system and in peripheral organs. Activation of certain subtypes of muscarinic receptors (M1, M3, M5) has been found to modulate DNA synthesis in a number of cell types. In several cell types acetylcholine, by activating endogenous or transfected muscarinic receptors, can indeed elicit cell proliferation. In other cell types, however, or under different experimental conditions, activation of muscarinic receptors has no effect, or inhibits DNA synthesis. A large number of intracellular pathways are being investigated to define the mechanisms involved in these effects of muscarinic receptors; these include among others, phospholipase D, protein kinases C and mitogen-activated-protein kinases. The ability of acetylcholine to modulate DNA synthesis through muscarinic receptors may be relevant in the context of brain development and neoplastic growth.


Subject(s)
DNA/biosynthesis , Receptors, Muscarinic/metabolism , Acetylcholine/metabolism , Acetylcholine/pharmacology , Animals , Cell Division/drug effects , Cell Division/physiology , Humans , Intracellular Fluid/metabolism , Muscarinic Agonists/pharmacology , Receptors, Muscarinic/classification , Signal Transduction/drug effects , Signal Transduction/physiology
3.
Curr Protoc Toxicol ; Chapter 12: Unit12.7, 2001.
Article in English | MEDLINE | ID: mdl-23045036

ABSTRACT

Cerebellar Granule Cells in Neurotoxicology (Jan Oberdoerster, Aventis Corporation, Research Triangle Park, North Carolina). Cultured neurons allow the researcher to investigate mechanisms of toxicity on a relatively uniform population of cells. Primary cultures of cerebellar granule cells are post-mitotic neurons that are readily isolated and may be used for experimental procedures including electrophysiology, neuronal maturation, and various biochemical and molecular analyses.


Subject(s)
Cerebellum/cytology , Cytoplasmic Granules , Animals , Animals, Newborn , Cell Separation , Cells, Cultured , Rats , Rats, Sprague-Dawley
4.
J Pharmacol Exp Ther ; 295(1): 295-301, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10991993

ABSTRACT

Phenylketonuria is a genetic defect that, without strict dietary control, results in the accumulation of phenylalanine (Phe) in body fluids. If a low-Phe diet is not maintained during pregnancy, the offspring of phenylketonuric women are born with mental retardation and microcephaly. Primary cultures of rat cerebellar granule cells, rat cortical astrocytes, human fetal astrocytes, and human neuroblastoma (SY5Y) cells and human astrocytoma (1321N1) cells were used to test the hypothesis that the microencephaly may be a result of neuronal cell death and reduced astrocyte proliferation. Exposure to Phe or to six Phe metabolites [phenylacetic acid (PAA), phenyllactic acid, hydroxyphenylacetic acid, phenylpyruvic acid, phenylethylamine (PEA), and mandelic acid] did not result in astroglial or neuronal cell cytotoxicity. Treatment of 1321N1 cells, human fetal astrocytes, or rat astrocytes with 5 mM Phe for 24 h decreased DNA synthesis 19 +/- 4, 30 +/- 4, and 60 +/- 6%, respectively. This effect was concentration dependent, and flow cytometry revealed that Phe treatment resulted in the accumulation of cells in the G(0)/G(1) phase of the cell cycle. In addition, in 1321N1 cells, exposure to 5 mM PAA, and in rat astrocytes, exposure to 0.5 mM PEA inhibited cell proliferation 42 +/- 4 and 55 +/- 4%, respectively. These metabolites also resulted in the accumulation of cells in the G(0)/G(1) phase of the cell cycle. In human fetal astrocytes, 0.5 mM PEA and 0.5 mM PAA resulted in a 41 +/- 12 and 52 +/- 11% reduction proliferation, respectively.


Subject(s)
Astrocytes/drug effects , Neurons/drug effects , Phenylalanine/pharmacology , Phenylketonuria, Maternal/complications , Cell Division/drug effects , Cell Survival/drug effects , Female , Humans , Phenethylamines/pharmacology , Pregnancy , Thymidine/metabolism , Tumor Cells, Cultured
5.
Eur J Pharmacol ; 385(2-3): 273-82, 1999 Dec 03.
Article in English | MEDLINE | ID: mdl-10607886

ABSTRACT

The effects of ethanol on cerebellar granule cell death were examined in cultures maintained for either 5 days in vitro (immature) or 8 and 12 days in vitro (mature). Ethanol did not alter cell survival under the usual growth conditions (i.e., 10% serum and 25 mM KCl). However, in mature cultures ethanol enhanced apoptosis induced by either serum withdrawal or incubation in non-depolarizing media. In immature cultures, serum deprivation, but not non-depolarizing media, resulted in granule cell death that was enhanced by ethanol. Serum removal increased both cleavage of the caspase-specific substrate N-acetyl-Asp-Glu-Val-Asp-7 amino-4-methylcoumarin (Ac-DEVD-amc) and the amount of active caspase-3. Inclusion of ethanol during the serum deprivation augmented Ac-DEVD-amc cleavage without further increasing the amount of active caspase-3. This study demonstrates that when neurotrophic factors are limiting, ethanol is toxic to cerebellar granule cells regardless of maturation status. The ability of ethanol to promote apoptosis involves an increase in caspase activity, but this does not entail an increase in the proteolytic activation of caspase-3.


Subject(s)
Apoptosis/drug effects , Caspases/metabolism , Cerebellum/drug effects , Ethanol/toxicity , Animals , Cell Count/drug effects , Cell Survival/drug effects , Cells, Cultured , Cerebellum/cytology , Cerebellum/enzymology , Coumarins/metabolism , Coumarins/pharmacology , Culture Media, Serum-Free/pharmacology , Hydrogen Peroxide/pharmacology , N-Methylaspartate/pharmacology , Oligopeptides/metabolism , Oligopeptides/pharmacology , Oxidants/pharmacology , Potassium Chloride/pharmacology , Rats
6.
Life Sci ; 64(23): PL 267-72, 1999.
Article in English | MEDLINE | ID: mdl-10372659

ABSTRACT

The present study was undertaken to determine whether the neurotoxic effects of ethanol vary between undifferentiated and differentiated neurons. For this study, untreated rat pheochromocytoma (PC12) cells and PC12 cells treated for 8-10 days with nerve growth factor (NGF) were used as models of undifferentiated and differentiated neurons, respectively. Treatment of differentiated PC12 cells with 150 mM ethanol resulted in a loss of cells whereas a similar treatment of undifferentiated cells had no effect. In contrast, 50 mM ethanol enhanced apoptosis initiated by serum withdrawal in undifferentiated cells while a similar response in the differentiated cells required 150 mM ethanol. This study demonstrates that undifferentiated and differentiated neuronal cells differ in their sensitivity to the neurotoxic actions of ethanol.


Subject(s)
Apoptosis/drug effects , Ethanol/adverse effects , Nerve Growth Factors/pharmacology , Animals , Cell Death/drug effects , Cell Differentiation/drug effects , Cell Survival/drug effects , Culture Media/pharmacology , Culture Media, Serum-Free/pharmacology , DNA/drug effects , DNA/metabolism , DNA Fragmentation/drug effects , PC12 Cells/cytology , PC12 Cells/drug effects , PC12 Cells/physiology , Rats
7.
J Pharmacol Exp Ther ; 287(1): 359-65, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9765357

ABSTRACT

Our goal was to examine the effects of ethanol on cell death using rat pheochromocytoma (PC12) cells as a neuronal model. Withdrawal of serum for 24 hr increased the number of PC12 cells labeled with ethidium homodimer indicating an increase in cell death. Inclusion of 50 mM ethanol during the serum deprivation further increased the amount of ethidium fluorescence by 39%. Although reducing the serum concentration from the usual 15 to 4% did not alter cellular viability, a significant increase in the amount of ethidium fluorescence was observed in PC12 cells incubated for 24 hr in the presence of 4% serum and 150 mM ethanol. No change in viability was observed in cells exposed to either 150 mM ethanol in the presence of 15% serum or 50 mM ethanol in the presence of 4% serum. Inclusion of ethanol during serum deprivation increased the amount of soluble DNA found in the 15,000 x g supernatant. Similarly, using the terminal deoxynucleotidyl transferase dUTP nick-end labeling method to visualize DNA fragmentation in situ, ethanol caused a 213% increase in the number of PC12 cells labeled during serum withdrawal. Agarose gel electrophoresis of the DNA isolated from cells maintained in the absence of serum yielded the classical DNA laddering pattern of 180 to 200 bp fragments suggestive of apoptosis. Ethanol caused a concentration-dependent increase in the amount of DNA laddering in cells deprived of serum. Furthermore, ethanol significantly potentiated the DNA laddering of cells maintained in 4% serum. In contrast to the ethanol-induced increase in cell death when serum factors were reduced or withdrawn, 150 mM ethanol lowered by 34% the number of ethidium-labeled PC12 cells observed after a 30-min exposure to 2 mM H2O2. Similarly, agarose gel electrophoresis of the DNA from H2O2-treated cells did not display DNA laddering. This study demonstrates that: 1) ethanol antagonizes the trophic action of serum factors; 2) pharmacologically relevant ethanol concentrations significantly potentiate apoptosis after serum withdrawal and 3) this enhancement appears specific for apoptosis.


Subject(s)
Cell Death/drug effects , Ethanol/toxicity , Neurons/drug effects , Animals , Apoptosis/drug effects , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Nerve Growth Factors , Nerve Tissue Proteins/drug effects , PC12 Cells , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...